17-82832566-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024702.3(ZNF750):c.-112A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.823 in 943,716 control chromosomes in the GnomAD database, including 321,698 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.81 ( 49787 hom., cov: 33)
Exomes 𝑓: 0.83 ( 271911 hom. )
Consequence
ZNF750
NM_024702.3 5_prime_UTR
NM_024702.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.919
Genes affected
ZNF750 (HGNC:25843): (zinc finger protein 750) This gene encodes a protein with a nuclear localization site and a C2H2 zinc finger domain. Mutations in this gene have been associated with seborrhea-like dermatitis with psoriasiform elements. [provided by RefSeq, Jul 2008]
TBCD (HGNC:11581): (tubulin folding cofactor D) Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 17-82832566-T-G is Benign according to our data. Variant chr17-82832566-T-G is described in ClinVar as [Benign]. Clinvar id is 1237571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.897 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF750 | NM_024702.3 | c.-112A>C | 5_prime_UTR_variant | 2/3 | ENST00000269394.4 | NP_078978.2 | ||
TBCD | NM_005993.5 | c.1318+17632T>G | intron_variant | ENST00000355528.9 | NP_005984.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF750 | ENST00000269394.4 | c.-112A>C | 5_prime_UTR_variant | 2/3 | 1 | NM_024702.3 | ENSP00000269394 | P1 | ||
TBCD | ENST00000355528.9 | c.1318+17632T>G | intron_variant | 1 | NM_005993.5 | ENSP00000347719 | P1 |
Frequencies
GnomAD3 genomes AF: 0.806 AC: 122565AN: 152086Hom.: 49752 Cov.: 33
GnomAD3 genomes
AF:
AC:
122565
AN:
152086
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.826 AC: 654087AN: 791512Hom.: 271911 Cov.: 11 AF XY: 0.820 AC XY: 339552AN XY: 414070
GnomAD4 exome
AF:
AC:
654087
AN:
791512
Hom.:
Cov.:
11
AF XY:
AC XY:
339552
AN XY:
414070
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.806 AC: 122659AN: 152204Hom.: 49787 Cov.: 33 AF XY: 0.806 AC XY: 60012AN XY: 74426
GnomAD4 genome
AF:
AC:
122659
AN:
152204
Hom.:
Cov.:
33
AF XY:
AC XY:
60012
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2758
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 13, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at